Lorena Roselló-Jiménez, Raúl Pastor, Marta Miquel, Laura Font
{"title":"Sex-specific exploration patterns and noradrenergic modulation in object recognition memory: Role of the perirhinal cortex.","authors":"Lorena Roselló-Jiménez, Raúl Pastor, Marta Miquel, Laura Font","doi":"10.1007/s00213-026-07191-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Object recognition memory (ORM) relies on two processes: familiarity, mediated by the perirhinal cortex (PRH), and recollection, supported by the hippocampus (HIP). These processes are recruited depending on memory strength: brief exploration forms weak traces relying on PRH familiarity, whereas extended exploration produces strong traces requiring HIP recollection. Noradrenaline (NA) modulates these mechanisms via β2-adrenergic receptors (β2-AR), influencing memory strength and consolidation. However, whether this modulation differs between sexes under conditions generating weak versus strong memory traces remains unknown. We examined how NA and β2-AR influence ORM in male and female mice under these conditions.</p><p><strong>Methods: </strong>Swiss mice were tested in the Novel Object Recognition task using training durations of 1-10 min and delays of 24-48 h. Atomoxetine (ATO) was used to increase NA levels, and ICI-118,551 (ICI) to block β2-AR. Neural activation was assessed via c-Fos immunohistochemistry in PRH and HIP.</p><p><strong>Results: </strong>Females showed greater efficiency in object processing, requiring less exploration than males. Under weak training conditions, ATO facilitated the formation of long-term ORM in females but not in males, accompanied by increased PRH c-Fos expression without HIP involvement. β2-AR blockade impaired ORM acquisition only in females, with no significant changes in c-Fos. In males, performance depended on object dissimilarity; increased NA did not enhance ORM unless stimuli were highly distinct.</p><p><strong>Conclusions: </strong>These findings reveal sex differences in noradrenergic modulation of ORM. In females, NA acting via β2-AR supports memory formation through PRH-dependent familiarity, emphasizing the importance of sex as a biological variable in research.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-026-07191-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Object recognition memory (ORM) relies on two processes: familiarity, mediated by the perirhinal cortex (PRH), and recollection, supported by the hippocampus (HIP). These processes are recruited depending on memory strength: brief exploration forms weak traces relying on PRH familiarity, whereas extended exploration produces strong traces requiring HIP recollection. Noradrenaline (NA) modulates these mechanisms via β2-adrenergic receptors (β2-AR), influencing memory strength and consolidation. However, whether this modulation differs between sexes under conditions generating weak versus strong memory traces remains unknown. We examined how NA and β2-AR influence ORM in male and female mice under these conditions.
Methods: Swiss mice were tested in the Novel Object Recognition task using training durations of 1-10 min and delays of 24-48 h. Atomoxetine (ATO) was used to increase NA levels, and ICI-118,551 (ICI) to block β2-AR. Neural activation was assessed via c-Fos immunohistochemistry in PRH and HIP.
Results: Females showed greater efficiency in object processing, requiring less exploration than males. Under weak training conditions, ATO facilitated the formation of long-term ORM in females but not in males, accompanied by increased PRH c-Fos expression without HIP involvement. β2-AR blockade impaired ORM acquisition only in females, with no significant changes in c-Fos. In males, performance depended on object dissimilarity; increased NA did not enhance ORM unless stimuli were highly distinct.
Conclusions: These findings reveal sex differences in noradrenergic modulation of ORM. In females, NA acting via β2-AR supports memory formation through PRH-dependent familiarity, emphasizing the importance of sex as a biological variable in research.
期刊介绍:
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.